Jove
Visualize
Contact Us

Related Experiment Videos

[TGF beta subtypes in hepatocellular carcinoma].

Z Pan1, B Yang, Y Liu

  • 1Liver Cancer Institute, Zhongshan Hospital, Shanghai Medical University.

Zhonghua Yi Xue Za Zhi
|October 20, 2000
PubMed
Summary

High expression of TGF beta 1 or TGF beta 2 in hepatocellular carcinoma (HCC) is linked to tumor recurrence. This finding aids in understanding HCC progression and patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural changes and relaxations monitored by luminescence.

Luminescence : the journal of biological and chemical luminescence·2012
Same author

Synthesis and cytotoxic activity of 3-phenyl-2-thio-quinoxaline 1,4-dioxide derivatives in hypoxia and in normoxia.

Drug discoveries & therapeutics·2012
Same author

Detection of quantitative trait loci for growth- and fatness-related traits in a large-scale White Duroc × Erhualian intercross pig population.

Animal genetics·2012
Same author

A genome scan for loci affecting adipocyte size and number in abdominal fat in a White Duroc × Erhualian F2 resource population.

Animal : an international journal of animal bioscience·2012
Same author

Detection of quantitative trait loci for porcine susceptibility to enterotoxigenic Escherichia coli F41 in a White Duroc × Chinese Erhualian resource population.

Animal : an international journal of animal bioscience·2012
Same author

A study on indoor environment contaminants related to dust mite in dwellings of allergic asthma patients and of healthy subjects.

Bioscience trends·2012
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunohistochemistry

Context:

  • Hepatocellular carcinoma (HCC) is a significant global health concern.
  • Understanding the molecular mechanisms driving HCC recurrence is crucial for improving patient prognosis.
  • Transforming growth factor beta (TGF-β) signaling plays a complex role in cancer development.

Purpose:

  • To investigate the expression levels of three TGF-β isoforms (TGF-β1, TGF-β2, TGF-β3) in HCC tissues.
  • To determine the clinicopathological significance of TGF-β isoform expression, specifically its association with HCC recurrence.
  • To analyze the relationship between TGF-β protein immunoreactivity and tumor recurrence in HCC patients.

Summary:

  • Immunohistochemistry was used to assess TGF-β protein expression in 52 HCC surgical specimens.
  • Specimens were categorized into recurrence (G1) and non-recurrence (G2) groups based on two-year post-resection outcomes.
  • Higher immunoreactivity rates for TGF-β1 and TGF-β2 were observed in the recurrence group (G1) compared to the non-recurrence group (G2).
  • A statistically significant difference in TGF-β1 and TGF-β2 expression was found between the groups, while TGF-β3 showed no significant difference.

Impact:

  • The study identifies TGF-β1 and TGF-β2 as potential biomarkers for predicting HCC recurrence.
  • Findings suggest that elevated TGF-β1 or TGF-β2 expression may indicate a higher risk of tumor relapse after resection.
  • This research contributes to a deeper understanding of TGF-β's role in HCC pathogenesis and offers insights for future therapeutic strategies targeting TGF-β signaling.

Related Experiment Videos